We are live on ! Find out more
HAE icon

Haemonetics
HAE

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 328 → 324 (-4)

6.15% less ownership

Funds ownership: 108.62% → 102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M

Top Buyers

1
ICM
Invenomic Capital Management
Massachusetts
+$43.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$19.2M
3
Boston Partners
Boston Partners
Massachusetts
+$15.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$15.2M
5
RRAM
River Road Asset Management
Kentucky
+$14.7M

Top Sellers

1
Holocene Advisors
Holocene Advisors
New York
-$82M
2
Citadel Advisors
Citadel Advisors
Florida
-$67.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.9M
4
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss
Texas
-$41.9M
5
William Blair Investment Management
William Blair Investment Management
Illinois
-$25.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair Investment Management
326
William Blair Investment Management
Illinois
– -$25.2M -314,654 Closed
Loomis, Sayles & Company
327
Loomis, Sayles & Company
Massachusetts
– -$12.4M -154,247 Closed
Norges Bank
328
Norges Bank
Norway
– -$10.1M -125,927 Closed
SCM
329
Steadfast Capital Management
New York
– -$7.36M -91,800 Closed
SIC
330
Schwartz Investment Counsel
Michigan
– -$5.21M -65,000 Closed
CM
331
Castleark Management
Illinois
– -$3.87M -48,300 Closed
Tudor Investment Corp
332
Tudor Investment Corp
Connecticut
– -$3.67M -45,776 Closed
EP
333
Edgestream Partners
New Jersey
– -$2.2M -27,420 Closed
Balyasny Asset Management
334
Balyasny Asset Management
Illinois
– -$1.51M -18,825 Closed
FRM
335
Fox Run Management
Connecticut
– -$1.37M -17,151 Closed
QT
336
Quantbot Technologies
New York
– -$1.35M -16,828 Closed
ACM
337
Aquatic Capital Management
Illinois
– -$1.28M -16,003 Closed
LCM
338
Legato Capital Management
California
– -$1.06M -13,194 Closed
Verition Fund Management
339
Verition Fund Management
Connecticut
– -$906K -11,300 Closed
SSA
340
Schonfeld Strategic Advisors
New York
– -$747K -9,321 Closed
Walleye Trading
341
Walleye Trading
New York
– -$547K -6,822 Closed
VCA
342
Verdence Capital Advisors
Maryland
– -$506K -6,313 Closed
CMF
343
Counterpoint Mutual Funds
California
– -$505K -6,295 Closed
QC
344
Quadrature Capital
United Kingdom
– -$494K -6,160 Closed
VF
345
Virtu Financial
New York
– -$452K -5,645 Closed
FC
346
FORA Capital
Florida
– -$438K -5,468 Closed
SFA
347
Sequoia Financial Advisors
Ohio
– -$359K -4,480 Closed
MF
348
Magnetar Financial
Illinois
– -$349K -4,356 Closed
AC
349
AXQ Capital
New Jersey
– -$325K -4,054 Closed
PCA
350
Pallas Capital Advisors
Massachusetts
– -$306K -3,814 Closed
12 13
14
15 16

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.